Hyliion is trading at $4.29 (up 5.9%) as the stock continues to rebound from last week’s sharp drop tied to a short-seller report and a securities fraud investigation.

  • Investors appear to be bargain-hunting following the recent selloff as the market reassesses the impact of the allegations.
  • Recent analyst coverage highlights strong Buy ratings and a stabilizing share price, signaling renewed confidence in the company's growth pipeline.